Heterocyclyamide-substituted imidazoles

Details Heterocyclyamide-substituted imidazoles Heterocyclyamide-substituted imidazoles

2011-04-05

2011-04-05

Coleman, Brenda L (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S252110, C514S252190, C514S253090, C514S254020, C514S254050, C514S254070, C540S575000, C544S295000, C544S357000, C544S364000, C544S369000, C544S370000

Reexamination Certificate

active

07919489

ABSTRACT:
The invention relates to heterocyclylamide-substituted imidazoles and methods for their preparation, their use for the treatment and/or prophylaxis of diseases as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, in particular for the use as antiviral agents, especially against cytomegaloviruses.

REFERENCES:
patent: 2008/0004275 (2008-01-01), Zimmermann et al.
patent: 2 508 788 (2004-06-01), None
patent: WO-98/52558 (1998-11-01), None
patent: WO-99/23091 (1999-05-01), None
patent: WO-00/34261 (2000-06-01), None
patent: WO-00/42043 (2000-07-01), None
patent: WO-2004/052852 (2004-06-01), None
patent: WO-2005/092865 (2005-10-01), None
patent: WO-2006/089664 (2006-08-01), None
Kuhle, Reactive Monomeric Carbonic Acid Derivatives, Angew. Chem. Internat. Edit., vol. 12, No. 8, pp. 630-643, 1973.
Chong et al., Abstracts of 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1999, p. 441.
Cinatl Jr. et al., FEMS Microbiology Reviews (2004) 28:59-77.
Kraemer et al., Cancer Research (1983) 43:4822-4827.
PCT Patent No. WO 2005/092865, International Publication Date: Oct. 6, 2005 (English abstract only).
English translation of the International Preliminary Report on Patentability for PCT/EP2006/001325, mailed Sep. 20, 2007, 9 pages.
Morissette et al., Advanced Drug Delivery Reviews (2004)56:275-300.
Vippagunta et al., Advanced Drug Delivery Reviews (2001)48:3-26.
“HIV-AIDS” Retrieved online via Internet [Mar. 25, 2009], URL: http://www.mayoclinic.com/health/hiv-aids/DS00005, Aug. 9, 2008.
Non-Final Office Action from U.S. Appl. No. 10/594,343, mailed on Mar. 30, 2009.
Amendment in Response to Non-Final Office Action from U.S. Appl. No. 10/594,343, filed Jun. 29, 2009.
Chaimbault et al., Pharmacy and Pharmacology Communications (1999) 5(3):211-215.

Affiliated with

Also associated with

Rating

Heterocyclyamide-substituted imidazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclyamide-substituted imidazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclyamide-substituted imidazoles will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2622954